Last reviewed · How we verify
NCT04474730
Physical Activity Monitoring Among BMT Patients
NA trial testing BMT Physical Activity app in Bone Marrow Transplantation in 21 participants. Completed in 31 March 2022.
31 March 2021
Quick facts
| Lead sponsor | Ming-Yuan Chih |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | device feasibility |
| Enrollment | 21 |
| Start date | 1 November 2019 |
| Primary completion | 31 March 2021 |
| Estimated completion | 31 March 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- BMT Physical Activity app
- Watch Only
Conditions studied
- Bone Marrow Transplantation — all drugs for Bone Marrow Transplantation →
Sponsor
Ming-Yuan Chih
Who can join
18 and older, any sex, with Bone Marrow Transplantation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to evaluate the feasibility of an apple watch-based application to promote physical activity among bone marrow transplant (BMT) patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04474730
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Bone Marrow Transplantation
Currently open trials in the same condition.
- NCT07205523 — High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT) · recruiting
- NCT04645199 — National Longitudinal Cohort of Hematological Diseases · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04474730 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ming-Yuan Chih
- Last refreshed: 31 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04474730.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing